“The facility is a fully functioning biomanufacturing plant with extraction technology to fractionate and crystalise during the manufacturing process, and a high-quality purification system,” the company says in a statement due to be released today to the ASX.
This is the PERFECT acquisition to allow our grow facility to transport all raw materials to our own processing facility that provides the capability to make high end medical oils and extracts.
Purification is critical and this plant also features this ability in droves.
This plant complements our growing facility. It is for a completely different purpose, and allows end to end production once the license comes in.
We will now officially hit the ground running.
THC Price at posting:
61.0¢ Sentiment: Buy Disclosure: Held
(20min delay)